Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Lipocalin 2 (LCN2) in experimental liver injury — Erawan Borkham‐Kamphorst (2010) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Lipocalin 2 (LCN2) in experimental liver injury
RW
Shared by
Ralf Weiskirchen
Lipocalin 2 (LCN2) in experimental liver injury
Article
2010
de
Authors
EB
Erawan Borkham‐Kamphorst
FD
F Drews
RW
Ralf Weiskirchen
Related publications
Article
2011
Lipocalin-2 (LCN2) in experimental liver injury and human liver diseases
Erawan Borkham‐Kamphorst
,
HW Zimmermann
,
KR Karlmark
,
Eddy Van de Leur
,
Jessica Bauer
,
Frank Tacke
,
Ralf Weiskirchen
Article
2015
Lipocalin 2 (LCN2) in hepatic inflammation
Anastasia Asimakopoulou
,
Erawan Borkham‐Kamphorst
,
Abstract
1 min read
LCN2 is a member of the lipocalin super-family with a diverse functionality, including transport of fatty acids and apoptosis induction.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Ralf Weiskirchen
Article
2016
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
Anastasia Asimakopoulou
,
Sabine Weiskirchen
,
Ralf Weiskirchen
Article
2013
Protective effects of Lipocalin-2 (LCN2) in acute and chronic liver injury indicate a novel function in liver homeostasis
Erawan Borkham‐Kamphorst
,
Eddy Van de Leur
,
HW Zimmermann
,
KR Karlmark
,
Lidia Tihaa
,
Ute Haas
,
Frank Tacke
,
Thorsten Berger
,
TW Mak
,
Ralf Weiskirchen
Article
2017
Lipocalin-2 in Fructose-Induced Fatty Liver Disease
Jessica Lambertz
,
Thorsten Berger
,
Tak W. Mak
,
Josef van Helden
,
Ralf Weiskirchen
Discussion(0)
No comments yet. Be the first to comment.